Advertisement
CI vs UNH
Which Stock Would AI Choose? The Cigna Group (CI) vs. UnitedHealth Group (UNH) Stock Comparison
Key Takeaways
- CI is pivoting toward higher-margin specialty pharmacy and health services, while UNH is executing a margin-recovery strategy across its insurance and Optum businesses.
- UNH has delivered stronger recent momentum, with shares up roughly 20–30% year to date, whereas CI has lagged the broader market over the past year.
- CI trades at a notably lower earnings multiple (a forward price-to-earnings ratio near 10x versus roughly 20x for UNH), reflecting a different risk and growth profile.
- Both companies are reshaping their portfolios: CI exited its Medicare business and is streamlining operations, while UNH is prioritizing profitable membership over enrollment growth.
- Investor sentiment has diverged, with UNH drawing broad analyst upgrades and CI facing a more mixed, value-oriented view.
Introduction
Few sectors reward scale and diversification as consistently as U.S. managed care, which makes a head-to-head look at CI (The Cigna Group) and UNH (UnitedHealth Group) especially instructive. Both are diversified healthcare giants that combine insurance operations with pharmacy services and care delivery, yet their recent paths have diverged meaningfully. This stock comparison is most relevant for investors weighing a lower-priced, transformation-focused name against a large-cap leader in the midst of an earnings recovery. The analysis below reviews recent performance, growth drivers, and market positioning to clarify the trade-offs each stock presents in the current environment.
CI Overview and Recent Performance
The Cigna Group operates through two main pillars: Cigna Healthcare, which provides medical plans and benefits, and Evernorth Health Services, which houses pharmacy benefit management and specialty pharmacy operations. Following the 2025 divestiture of its Medicare businesses to Health Care Services Corporation, Cigna has sharpened its focus on employer-sponsored coverage and specialty care. Recent quarters have shown steady revenue growth, including a roughly 7% year-over-year increase in second-quarter revenue, supported by strong specialty pharmacy volume and growing adoption of biosimilars and generic specialty drugs.
In recent weeks, sentiment toward CI has been shaped by a CEO transition, an announced exit from the individual exchange market, and a strategic review of its eviCore utilization-management unit. The company is also rolling out a rebate-free "Signature" pharmacy model aimed at improving cost transparency. Shares have traded in the upper $200s to low $300s range, and the stock has underperformed the broader market over the past year. That weakness has left CI at a low valuation, with a forward price-to-earnings (P/E) ratio well below its historical average.
UNH Overview and Recent Performance
UnitedHealth Group is the largest U.S. health insurer by revenue, combining the UnitedHealthcare insurance franchise with Optum, which spans pharmacy benefit services (Optum Rx), care delivery (Optum Health), and data and technology (Optum Insight). After a difficult period marked by elevated medical costs and membership losses, UNH has delivered a notable earnings recovery. Third-quarter adjusted earnings per share (EPS) rose sharply year over year, while the medical care ratio—the share of premium revenue spent on care—improved, signaling better cost control and pricing discipline.
In recent weeks, UNH has raised its full-year adjusted EPS outlook, and analysts have responded with a wave of upward estimate revisions. Shares have rallied to the low $400s, gaining roughly 20–30% year to date and outperforming the sector. That strength comes even as membership declines persist, particularly in Medicare Advantage, where management is deliberately accepting lower enrollment to protect margins. The stock's momentum has pushed its valuation above historical norms, though it remains below many analysts' price targets.
Trending AI Robots
For traders seeking a systematic way to navigate divergences like the one between these two healthcare names, Tickeron's Trending AI Robots page offers a curated starting point. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and set of covered symbols. Because not every bot suits every market regime, Tickeron highlights only the most suitable performers for current conditions in this dedicated section, allowing users to compare statistics and recent results at a glance. Exploring the Trending AI Robots page can help investors quickly identify automated strategies aligned with today's market dynamics.
Head-to-Head Comparison
The two companies share structural similarities but diverge on several key dimensions. On business model, both blend insurance with pharmacy and care services, yet UNH's Optum platform is substantially larger and more integrated, giving it greater scale and cross-selling potential. CI, by contrast, is more concentrated in pharmacy benefit management and specialty pharmacy, which exposes it to ongoing scrutiny of the PBM (pharmacy benefit manager) industry.
On growth drivers, UNH is leaning on margin recovery, AI-enabled efficiency, and an Optum Health turnaround, while CI is betting on specialty expansion, biosimilar adoption, and its new Signature pharmacy model. On recent momentum, UNH has clearly outperformed, aided by consecutive guidance increases and positive estimate revisions; CI has lagged as investors weigh execution risks tied to its portfolio transition.
On risk factors, UNH faces regulatory scrutiny, legal pressure, and membership erosion, whereas CI carries PBM-transition uncertainty and a leadership change. On valuation and sentiment, CI screens cheaper on a forward P/E basis, appealing to value investors, while UNH commands a premium multiple that reflects its recent earnings momentum. The trade-off is essentially one of turnaround strength versus valuation discount.
Tickeron AI Verdict
Based on observable trend consistency, relative momentum, and the cadence of positive catalysts, Tickeron's AI would likely lean toward UNH in the current environment. The stock's improving medical cost trends, successive guidance raises, and cluster of upward analyst revisions suggest a more established and durable positive trajectory. CI offers an appealing valuation and a credible long-term strategy, but its transition is at an earlier, less certain stage. While this probabilistic read favors UNH on momentum and stability, CI's discount could make it the more compelling risk-reward setup for patient, value-focused investors.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Buy and UNH is a StrongBuy.
CI in upward trend: price rose above 50-day moving average on October 07, 2026
CI moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend. In 38 of 52 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on CI as a result. In 61 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for CI just turned positive on October 07, 2026. Looking at past instances where CI's MACD turned positive, the stock continued to rise in 32 of 50 cases over the following month. The odds of a continued upward trend are 64%.
The 10-day moving average for CI crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
The 50-day moving average for CI moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 222 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
CI broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.958) is normal, around the industry mean (3.582). P/E Ratio (12.994) is within average values for comparable stocks, (130.390). Projected Growth (PEG Ratio) (0.739) is also within normal values, averaging (0.786). CI has a moderately high Dividend Yield (0.020) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).
The Tickeron Price Growth Rating for this company is 26 (best 1 - 100 worst), indicating outstanding price growth. CI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
UNH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for UNH turned positive on October 05, 2026. Looking at past instances where UNH's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on UNH as a result. In 46 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 182 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UNH entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.875) is normal, around the industry mean (3.582). P/E Ratio (27.242) is within average values for comparable stocks, (130.390). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.022) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
CI | UNH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 36 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 41 | 89 | |
SMR RATING 1..100 | 55 | 58 | |
PRICE GROWTH RATING 1..100 | 26 | 42 | |
P/E GROWTH RATING 1..100 | 73 | 7 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CI's Valuation (24) in the Managed Health Care industry is somewhat better than the same rating for UNH (63). This means that CI’s stock grew somewhat faster than UNH’s over the last 12 months.
CI's Profit vs Risk Rating (41) in the Managed Health Care industry is somewhat better than the same rating for UNH (89). This means that CI’s stock grew somewhat faster than UNH’s over the last 12 months.
CI's SMR Rating (55) in the Managed Health Care industry is in the same range as UNH (58). This means that CI’s stock grew similarly to UNH’s over the last 12 months.
CI's Price Growth Rating (26) in the Managed Health Care industry is in the same range as UNH (42). This means that CI’s stock grew similarly to UNH’s over the last 12 months.
UNH's P/E Growth Rating (7) in the Managed Health Care industry is significantly better than the same rating for CI (73). This means that UNH’s stock grew significantly faster than CI’s over the last 12 months.
| CI | UNH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 55% |
| Advances ODDS (%) | 7 days ago 63% | 3 days ago 55% |
| Declines ODDS (%) | 22 days ago 55% | 10 days ago 53% |
| BollingerBands ODDS (%) | 1 day ago 62% | 1 day ago 52% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 56% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 2 FA rating(s) are green while UNH’s FA Score has 1 green FA rating(s).
- CI’s FA Score: 2 green, 3 red.
- UNH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 6 TA indicator(s) are bullish while UNH’s TA Score has 5 bullish TA indicator(s).
- CI’s TA Score: 6 bullish, 5 bearish.
- UNH’s TA Score: 5 bullish, 5 bearish.
Price Growth
CI (@Managed Health Care) experienced а +5.71% price change this week, while UNH (@Managed Health Care) price change was +4.50% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +2.49%. For the same industry, the average monthly price growth was +10.42%, and the average quarterly price growth was +42.97%.
Reported Earning Dates
CI is expected to report earnings on Nov 05, 2026.
UNH is expected to report earnings on Jan 20, 2027.
Industries' Descriptions
@Managed Health Care (+2.49% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
CI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.
UNH and
Correlation & Price change
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.